PROVIDER PROFILE · NPI 1497117444

Michael Hwang

Medical OncologyBaltimore, MDI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

271

Unique beneficiaries

—

Total services

927

Distinct HCPCS

Medicare payment

$122K

Peer benchmark

Total Medicare services vs. 114 Medical Oncology providers in MD — above median (cohort median 578).

PRESCRIBING · PART D · 2024

Total Rx claims

632

Beneficiaries

—

Total drug cost

$3.5M

Distinct drugs

Brand share

39.2%

Top prescribed drugs

Osimertinib Mesylate140 claims

Dexamethasone70 claims

Ondansetron Hcl64 claims

Oxycodone Hcl51 claims

Prednisone35 claims

QUALITY · MIPS · 2024

Final MIPS score

77.6

Quality

66.9

Cost

71.9

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.11%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$260

Payment records

By payment type

Consulting Fee$260

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history